The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Living With HIV: Watch Aaron's Story
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

Financial Times Examines Intellectual Property Debate in India

May 16, 2013

The Financial Times examines how the "struggle of educated, middle-class patients to obtain cutting-edge medicine ... has led to a showdown between India and western pharmaceutical companies over the patents and prices of lifesaving drugs" in the country. The newspaper writes, "Western drugmakers fear India will inspire other emerging markets to challenge their patents," adding, "They have accused India of trampling on their intellectual property rights after a series of decisions overriding, revoking or refusing patents on cancer and hepatitis C drugs from Bayer, Pfizer, Roche and Novartis."

"At a recent U.S. congressional hearing, Roy Waldron, Pfizer's chief intellectual property officer, complained that New Delhi had 'routinely flouted trade rules to bolster the Indian generics industry,'" the

View Full Article

  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
See Also
More on HIV/AIDS Treatment in India

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining: